Abstract
New World indigenous peoples are noted for their sophisticated use of psychedelic plants in shamanic and ethnomedical practices. The use of psychedelic plant preparations among New World tribes is far more prevalent than in the Old World. Yet, although these preparations are botanically diverse, almost all are chemically similar in that their active principles are tryptamine derivatives, either DMT or related constituents. Part 1 of this paper provides an ethnopharmacological overview of the major tryptamine-containing New World hallucinogens. Part 2 focuses on ayahuasca and its effects on the human brain. Using complementary neurophysiological and neuroimaging techniques, we have identified brain areas involved in the cognitive effects induced by this complex botanical preparation. Initial SPECT data showed that ayahuasca modulated activity in higher order association areas of the brain. Increased blood perfusion was observed mainly in anterior brain regions encompassing the frontomedial and anterior cingulate cortices of the frontal lobes, and in the medial regions of the temporal lobes. On the other hand, applying spectral analysis and source location techniques to cortical electrical signals, we found changes in neuronal activity that predominated in more posterior sensory-selective areas of the brain. Now, using functional connectivity analysis of brain oscillations we have been able to reconcile these seemingly contradictory findings. By measuring transfer entropy, a metric based on information theory, we have shown that ayahuasca temporarily modifies the ordinary flow of information within the brain. We propose a model in which ayahuasca reduces top-down constraints and facilitates bottom-up information transfer. By simultaneously enhancing endogenous cortical excitability and reducing higher-order cognitive control, ayahuasca temporarily disrupts neural hierarchies allowing inner exploration and a new outlook on reality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Borhegyi SF (1961) Miniature mushroom stones from Guatemala. Am Antiq 26:498–504
Bouso JC, Palhano-Fontes F, Rodríguez-Fornells A, Ribeiro S, Sanches R, Crippa JA, Hallak JEC, de Araujo DB, Riba J (in press) Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol
Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Ribeiro Barbosa PC, Alcázar-Córcoles MÁ, Araújo WS, Barbanoj MJ, Fábregas JM, Riba J (2012) Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study. PLoS ONE 7:e42421
Bouso JC, Fábregas JM, Antonijoan RM, Rodríguez-Fornells A, Riba J (2013) Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Psychopharmacology 230:415–424
Cavanna AE, Trimble MR (2006) The precuneus: a review of its functional anatomy and behavioural correlates. Brain 129:564–583
Cinq-Mars J, Morlan RE (1999) Bluefish caves and old crow basin: a new rapport. In: Bonnichsen R, and Turnmire KL (eds) Ice age peoples of North America, Corvallis: Oregon State University Press for the Center for the Study of the First Americans, pp. 200–212
Cloninger CR, Svrakic DM, Przybeck TR (1993) A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975–990
Cooper JM (1949) Stimulants and narcotics. In: Handbook of South American Indians, vol 5. Bureau of American Ethnology Bulletin #143. Smithsonian Institution, Washington
Dale GD (1991) The Santo Daime Doctrine: an interview with Alex Polari de Alverga. Shaman’s Drum 22:30–41
Daly JW, Witkop B (1971) Chemistry and pharmacology of frog venoms. In: Bücherl W, Buckley EE (eds) Venomous animals and their venoms, vol 2. Academic Press
Davis W, Weil AT (1992) Identity of a new world psychoactive toad. Ancient Mesoamerica 3:51–59
Davis W, Weil AT (1994) Bufo alvarius: a potent hallucinogen of animal origin. J Ethnopharmacol 41:1–8
De Araujo DB, Ribeiro S, Cecchi GA, Carvalho FM, Sanchez TA, Pinto JP, de Martinis BS, Crippa JA, Hallak JEC, Santos AC (2012) Seeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion. Hum Brain Mapp 33:2550–2560
Der Marderosian AH, Pinkley HV, Dobbins MF (1968) Native use and occurrence of N, N-dimethyltryptamine in the leaves of Banisteriopsis rusbyana. Am J Pharm 140:137–147
Emboden W (1979) Narcotic plants. Collier Books, New York
Erowid.org (2001a) A list of the (186) known psilocybin mushrooms. https://www.erowid.org/plants/mushrooms/mushrooms_info12.shtml. Accessed 27 Dec 2014
Erowid.org (2001b) Legal status of ayahuasca in Brazil. http://www.erowid.org/chemicals/ayahuasca/ayahuasca_law6.shtml. Accessed 29 Dec 2014
Erowid.org (2006) UDV wins Supreme Court decision on preliminary injunction. http://www.erowid.org/chemicals/ayahuasca/ayahuasca_law22.shtml. Accessed 29 Dec 2014
Erowid.org (2012) Santo Daime wins court decision. http://www.erowid.org/chemicals/ayahuasca/ayahuasca_law24.shtml. Accessed 29 Dec 2014
Fish MS, Johnson NM, Horning EC (1955) Piptadenia alkaloids—indole bases of Piptadenia peregrina (L.) Benth and related species. J Am Chem Soc 77:5892–5895
Frankel PS, Cunningham KA (2002) The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain. Brain Res 958:251–260
Friston K (2005) A theory of cortical responses. Philos Trans R Soc Lond B Biol Sci 360:815–836
Gates B (1979) New names in Banisteriopsis and Diplopterys (Malpighiaceae) of the Guayana highland. Brittonia 31:108–109
Gewirtz JC, Chen AC, Terwilliger R, Duman RC, Marek GJ (2002) Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors. Pharmacol Biochem Behav 73:317–326
González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439–452
Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H (1999) Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 20:565–581
Guzmán G, Allen JW, Garrtz J (2000) A worldwide geographical distribution of the neurotropic fungi, an analysis and discussion. Annalidei Museocivico - Rovereto, Italia 14:189–280 (in English)
Heim R, Hofmann A (1958) Isolement de la Psilocybine à partir du Stropharia cubensis Earle et d’autrese spèces de champignons hallucinogens mexicains appartenant au genre Psilocybe. Extrait des Comptesrendus des séances de l’Académie des Sciences, t 247:557–561
Hermle L, Fünfgeld M, Oepen G, Botsch H, Borchardt D, Gouzoulis E, Fehrenbach RA, Spitzer M (1992) Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research. Biol Psychiatry 32:976–991
Holmstedt B, Lindgren JE (1967) Chemical constituents and pharmacology of South American snuffs. In: Efron DH, Holmstedt B, Kline NS (eds) Ethnopharmacologic search for psychoactive drugs, US Public Health Service Publication #1645. US Government Printing Office
Kennedy AB (1982) Ecce Bufo: the toad in nature and in Olmec iconography. Curr Anthropol 23:273–290
Luna LE (1984) The concept of plants as teachers among four mestizo shamans of Iquitos, northeastern Peru. J Ethnopharmacol 11:135–156
Macrae WD, Towers GH (1984a) Justicia pectoralis: a study of the basis for its use as a hallucinogenic snuff ingredient. J Ethnopharmacol 12:93–111
Macrae WD, Towers GH (1984b) An ethnopharmacological examination of Virola elongata bark: a South American arrow poison. J Ethnopharmacol 12:75–92
McKenna DJ (2000) An unusual experience with “hoasca”: a lesson from the teacher. In: Ayahuasca Reader: encounters with the Amazon’s sacred vine. Synergetic Press, Santa Fe, pp 154–157
McKenna DJ, Towers GH, Abbott FS (1984a) Monoamine oxidase inhibitors in South American hallucinogenic plants part II: constituents of orally active Myristicaceous hallucinogens. J Ethnopharmacol 12:179–211
McKenna DJ, Towers GH, Abbott FS (1984b) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and ß-carboline constituents of ayahuasca. J Ethnopharmacol 10:195–223
McKenna DJ, Luna LE, Towers GH (1995) Biodynamic constituents in ayahuasca admixture plants: an uninvestigated folk pharmacopoeia. In: von Reis S, Schultes RE (eds) Ethnobotany: evolution of a discipline. Dioscorides Press, Portland
Mesulam MM (2000) Behavioral neuroanatomy: large-scale networks, association cortex, frontal syndromes, the limbic system, and hemispheric specializations. In: Mesulam MM (ed) Principles of behavioral and cognitive neurology. Oxford University Press, New York, pp 1–120
Mesulam M (2008) Representation, inference, and transcendent encoding in neurocognitive networks of the human brain. Ann Neurol 64:367–378
Metzner R (1999) Ayahuasca: hallucinogens, consciousness and the spirit of nature. Thunder’s Mouth Press, New York
Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013) Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci 33:15171–15183
Naranjo P (1995) Archeology and psychoactive plants. In: von Reis S, Schultes RE (eds) Ethnobotany: evolution of a discipline. Dioscorides Press, Portland
Ott J (1998) Pharmahuasca, anahuasca, vinho de Jurema: human pharmacology of oral DMT + harmine. In: Müller-Ebeling C (ed) Special: psychoactivity. Yearbook for ethnomedicine and the study of consciousness, 6/7 (1997–1998). Berlin, VWB
Ott J (2001) Pharmañopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine. J Psychoactive Drugs 33:273–281
Pachter IJ, Zacharius DE, Ribeiro O (1959) Indole alkaloids of Acer saccharinum (the silver maple), Dictyloma incanescens, Piptadenia colubrina, and Mimosa hostilis. J Org Chem 24:1285–1287
Pinkley HV (1969) Plant admixtures to ayahuasca, the South American hallucinogenic drink. Lloydia 32:305–314
Riba J, Anderer P, Jané F, Saletu B, Barbanoj MJ (2004) Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology 50:89–101
Riba J, Romero S, Grasa E, Mena E, Carrió I, Barbanoj MJ (2006) Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology 186:93–98
Rivier L, Lindgren J (1972) Ayahuasca, the South American hallucinogenic drink: ethnobotanical and chemical investigations. Econ Bot 29:101–129
Roland PE, Gulyás B (1994) Visual imagery and visual representation. Trends Neurosci 17:281–287; discussion 294–297
Sakai K, Miyashita Y (1994) Visual imagery: an interaction between memory retrieval and focal attention. Trends Neurosci 17:287–289
Schultes RE (1969) Virola as an orally administered hallucinogen. Harvard Bot Mus Leaflets 22:229–240
Schultes RE (1970a) The New World Indians and their hallucinogenic plants. Morris Arboretum Bull 21:3–14
Schultes RE (1970b) The plant kingdom and hallucinogens (part III). Bull Narc 22:25–53
Schultes RE, Hofmann A (1981) The botany and chemistry of hallucinogens, 2nd edn. Charles C. Thomas Publishers, Springfield, Illinois
Schultes RE, Hofmann A (2001) Plants of the gods: their sacred, healing, and hallucinogenic powers. Healing Arts Press
Schultes RE, Holmstedt B (1968) The vegetal ingredients of the Myristicaceous snuffs of the Northwest Amazon. Rhodora 70:113–160
Smith TA (1977) Tryptamine and related compounds in plants. Phytochemistry 16:171–175
Torres CM (1995) Archeological evidence for the antiquity of psychoactive plant use in the central Andes. Ann Mus Civ Reverero 11:291–326
Torres CM, Repke DB (2006) Anadenanthera: visionary plant of ancient South America. Routledge, London
Torres CM, Repke DB, Chan K, McKenna D, Llagostera A, Schultes RE (1992) Botanical, chemical, and contextual analysis of archaeological snuff powders from San Pedro de Atacama, Northern Chile. Curr Anthropol 32:640–649
Vepsäläinen JJ, Auriola S, Tukiainen M, Ropponen N, Callaway JC (2005) Isolation and characterization of yuremamine, a new phytoindole. Planta Med 71:1053–1057
Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16:357–372
Wassén SH (1964) Some general viewpoints in the study of native drugs especially from the West indies and South America. Ethnos 1–2:97–120
Wassén SH (1967) Anthropological survey of the use of South American snuffs. In: Efron DH, Holmstedt B, Kline NS (eds) Ethnopharmacologic search for psychoactive drugs, US Public Health Service Publication #1645. US Government Printing Office
Wasson RG (1968) Soma: divine mushroom of immortality. Harcourt, Brace, Jovanovich
Wasson RG (1980) The wondrous mushroom: mycolatry in Mesoamerica. McGraw-Hill Book Company, New York
Wasson RG, Wasson V (1957) Seeking the magic mushroom. Life Magazine, 13 May 1957
Weil AT, Davis W (1994) Bufo alvarius: a potent hallucinogen of animal origin. J Ethnopharmacol 41(1–2):1–8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
McKenna, D., Riba, J. (2016). New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca. In: Halberstadt, A.L., Vollenweider, F.X., Nichols, D.E. (eds) Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7854_2016_472
Download citation
DOI: https://doi.org/10.1007/7854_2016_472
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55878-2
Online ISBN: 978-3-662-55880-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)